• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Acorda Therapeutics Inc

+ Add to Watchlist

ACOR:US

29.8800 USD 0.2200 0.73%

As of 20:10:00 ET on 07/21/2014.

Snapshot for Acorda Therapeutics Inc (ACOR)

Open: 29.9700 Day's Range: 29.5200 - 30.0775 Volume: 271,978
Previous Close: 30.1000 52wk Range: 27.5100 - 39.9450 1-Yr Rtn: -19.87%

Stock Chart for ACOR

No chart data available.
  • ACOR:US 29.8900
  • 1D
  • 1M
  • 1Y
30.1000
Interactive ACOR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ACOR

Current P/E Ratio (ttm) 65.8364
Estimated P/E(12/2014) 31.4858
Relative P/E vs. SPX 3.6156
Earnings Per Share (USD) (ttm) 0.4539
Est. EPS (USD) (12/2014) 0.9490
Est. PEG Ratio 0.5573
Market Cap (M USD) 1,246.99
Shares Outstanding (M) 41.73
30 Day Average Volume 718,758
Price/Book (mrq) 2.7219
Price/Sale (ttm) 3.5045
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/01/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ACOR

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ACOR

Acorda Therapeutics Inc. is a biotechnology company that is developing therapies for spinal cord injury and related neurological conditions, including multiple sclerosis. Additionally, Acorda is developing multiple approaches to regeneration and repair of the spinal cord and brain.

Ron CohenPresident/CEO/FounderMichael W RogersChief Financial Officer
Andrew HindmanChief Business Development OfcrEnrique J CarrazanaChief Medical Officer
More Company Profile & Key Executives for ACOR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil